Literature DB >> 7558926

HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy.

W M Howell1, S T Leung, D B Jones, I Nakshabendi, M A Hall, J S Lanchbury, P J Ciclitira, D H Wright.   

Abstract

CD is a gluten-sensitive enteropathy, strongly associated with expression of the DQA1*0501, DQB1*0201 genotype. CD patients have an increased risk of malignancy, particularly EATCL. However, it is controversial as to whether adults with EATCL represent a subgroup of patients with CD or should be regarded as a distinct entity. To investigate the genetic relationship between CD and EATCL, HLA class II DRB1, DQA1, and DQB1 typing of peripheral blood, frozen or paraffin-embedded biopsy tissue obtained from Caucasian patients with CD (n = 91) or EATCL (n = 47) was performed by PCR-SSOP typing. Genotype frequencies were compared with those observed in 151 unrelated control individuals. A total of 83 (91%) of 91 CD patients were of DQA1*0501, DQB1*0201 genotype (pc < 10(-6), RR = 522.2), compared with 40 (93%) of 43 EATCL patients (pc < 10(-6), RR = 44.2) with amplifiable DNA versus 35 (23%) of 151 controls. DRB1*03 frequencies were also elevated in both patient groups (79 of 91 in CD [87%; pc < 10(-6), RR = 24.5] and 38 of 40 in EATCL [95%; pc < 10(-6), RR = 70.7]) compared with controls (32 of 151, 21%). These results confirm previous studies of HLA associations in CD and also suggest that EATCL arises in individuals with the DQA1*0501, DQB1*0201 CD-predisposing genotype. However, the frequency of DRB1*03,04 heterozygotes was significantly increased in the EATCL group (16 of 40, 40%) compared with both control individuals (3 of 151, 2%; pc < 10(-6), RR = 32.9) and uncomplicated CD patients (6 of 91, 7%; pc = 0.04, RR = 9.4).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558926     DOI: 10.1016/0198-8859(94)00130-i

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

1.  Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy-type T-cell lymphoma.

Authors:  Pavlina Cejkova; Andreas Zettl; Anne K Baumgärtner; Andreas Chott; German Ott; Hans Konrad Müller-Hermelink; Petr Starostik
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

2.  The role of human leucocyte antigen genes in the development of malignant disease.

Authors:  W M Howell; D B Jones
Journal:  Clin Mol Pathol       Date:  1995-12

Review 3.  Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.

Authors:  Michal K Sieniawski; Anne L Lennard
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

Review 4.  Pathogenesis of Enteropathy-Associated T Cell Lymphoma.

Authors:  Udit Chander; Rebecca J Leeman-Neill; Govind Bhagat
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

5.  Genetic analysis of hydatidiform moles in paraffin wax embedded tissue using rapid, sequence specific PCR-based HLA class II typing.

Authors:  A C Bateman; S K Hemmatpour; J M Theaker; W M Howell
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

6.  HLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast.

Authors:  A H Lee; A C Bateman; S J Turner; J M Theaker; W M Howell
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

7.  Polymerase chain reaction based human leucocyte antigen genotyping for the investigation of suspected gastrointestinal biopsy contamination.

Authors:  A C Bateman; S J Turner; J M Theaker; B F Warren; W M Howell
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 8.  Celiac disease-associated autoimmune endocrinopathies.

Authors:  V Kumar; M Rajadhyaksha; J Wortsman
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

9.  Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression.

Authors:  I N Farstad; F-E Johansen; L Vlatkovic; J Jahnsen; H Scott; O Fausa; A Bjørneklett; P Brandtzaeg; T S Halstensen
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.

Authors:  A Chott; W Haedicke; I Mosberger; M Födinger; K Winkler; C Mannhalter; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.